[1]蒋佳红,李 游,邓知敏,等.外泌体在肝癌中的应用研究[J].医学信息,2020,33(24):28.[doi:10.3969/j.issn.1006-1959.2020.24.009]
　JIANG Jia-hong,LI You,DENG Zhi-min,et al.Study on the Application of Exosomes in Liver Cancer[J].Medical Information,2020,33(24):28.[doi:10.3969/j.issn.1006-1959.2020.24.009]
点击复制

外泌体在肝癌中的应用研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年24期
页码:
28
栏目:
综述
出版日期:
2020-12-15

文章信息/Info

Title:
Study on the Application of Exosomes in Liver Cancer
文章编号:
1006-1959（2020）24-0028-04
作者:
蒋佳红; 李 游; 邓知敏; 石媛媛; 卢丹阳; 杨 岚; 宋炜熙; 胡 琦
湖南中医药大学中西医结合学院，湖南 长沙 410208
Author(s):
JIANG Jia-hong; LI You; DENG Zhi-min; SHI Yuan-yuan; LU Dan-yang; YANG Lan; SONG Wei-xi; HU Qi
College of Integrated Chinese and Western Medicine,Hunan University of Chinese Medicine,Changsha 410208,Hunan,China
关键词:
肝癌; 外泌体; 侵袭; 转移
Keywords:
Liver cancer; Exosomes; Invasion; Metastasis
分类号:
R735.7
DOI:
10.3969/j.issn.1006-1959.2020.24.009
文献标志码:
A
摘要:
原发性肝癌发病率、死亡率居恶性肿瘤前列，近年来多学科综合治理和个性化治疗虽使患者5年生存率有所提高，但因其早期不易诊断且易转移、易复发的特点，仍严重威胁着人类生命健康。外泌体是一种能够的在细胞间进行物质交换和信息交流的胞外囊泡，通过促进新血管形成、抑制免疫细胞功能、改变肿瘤微环境等机制作用于肝癌的发生、发展过程。近年研究发现，外泌体可成为新的肿瘤标志物，且有望成为优良的药物载体和肝癌治疗的新靶点。本文主要就外泌体在肝癌的诊断、发生发展以及治疗中的作用进行综述，旨在为肝癌的诊断和治疗提供新的思路。
Abstract:
The incidence and mortality of primary liver cancer rank among the top of malignant tumors. In recent years, multidisciplinary comprehensive management and personalized treatment have improved the 5-year survival rate of patients, but due to its characteristics of early diagnosis, metastasis, and recurrence, It remains a serious threat to human life and health. Exosomes are extracellular vesicles that can exchange materials and information between cells. They play a role in the occurrence and development of liver cancer by promoting the formation of new blood vessels, inhibiting immune cell function, and changing the tumor microenvironment. It found, exosomes may be a new tumor marker, and is expected to be an excellent target for new pharmaceutical carriers and treatment of liver cancer. This article will summarize the role of exosomes in the diagnosis, development and treatment of liver cancer, and provide new research and clinical ideas for the diagnosis and treatment of liver cancer.

参考文献/References:

[1]Conigliaro A,Costa V,Lo Dico A,et al.CD90+liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA[J].Molecular Cancer,2015,14(1):155-155. [2]曾烨,Bingmei MFu.抗血管生成致内皮细胞释放外泌体促进肿瘤血管形成[J].医用生物力学,2019,34(S1):50. [3]尹春来.肝癌细胞来源外泌体促进M2型巨噬细胞极化并促进肝癌进展的机制研究[C]//中国免疫学会.第十二届全国免疫学学术大会分会场交流报告集.2017. [4]林世杰,周虎,张丽峰,等.HepG2肝癌细胞外泌体对人树突状细胞成熟与功能的影响[J].广西中医药,2019,42(4):65-72. [5]Li X,Sun W.Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis[J].Cancer Letters,2017,397(1):33-42. [6]Cheng L,Liu J,Liu Q,et al.Exosomes from melatonin treated hepatocellularcarcinoma cells alter the immunosupression status through stat3 pathway in macrophages[J].Int J Biol Sci,2017,13(6):723-734. [7]Fang JH,Zhang ZJ,Shang LR,et al.Hepatoma cell‐secreted exosomal microRNA‐103 increases vascular permeability and promotes metastasis by targeting junction proteins[J].Hepatology,2018,68(4):1459-1475. [8]Fang T,Lv H,Lv G,et al.Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer[J].Nature Communications,2018,9(1):191. [9]Fu X,Liu M,Qu S,et al.Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway[J].Journal of Experimental&Clinical Cancer Research,2018,37(1):52. [10]Takahashi K,Yan I K,Kogure T,et al.Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer[J].FEBS Open Bio,2014,(4):458-467. [11]屈振,法镇中,汤建军,等.肝癌患者血清外泌体内miR-665的表达及临床意义[J].肝胆胰外科杂志,2018,30(6):453-456. [12]Wang H,Hou L,Li A.Expression of Serum Exosomal MicroRNA-21 in Human Hepatocellular Carcinoma[J].BioMed Research International,2014(2014):52-57. [13]Shi M,Jiang Y,Yang L,et al.Decreased levels of serum exosomal miR-638predict poor prognosis in hepatocellular carcinoma[J].J Cell Biochem,2018,119 (6):4711-4716. [14]Liu W,Hu J,Zhou K,et al.Serum exosomal miR-125b is a novel prognostic marker for hepatocellul carcinoma[J].Onco Targets Ther,2017(10):3843-3851. [15]Lou G,Chen Z,Zheng M,et al.Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases[J].Experimental&Molecular Medicine,2017,49(6):e346. [16]何淑芳.肝癌治疗siRNA脂质纳米载体的设计及其高效递送机制的研究[D].中国科学院大学(中国科学院上海药物研究所),2019. [17]复旦大学附属中山医院.一种肝癌治疗性外泌体药物:中国专利,2019103833255[P].2019-08-02. [18]Lou G,Song X,Yang Fa,et al.Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma[J].Journal of Hematology&Oncology,2015(8):122. [19]Cheng LJ,Liu Q.Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages[J].International Journal of Biological Sciences,2017,13(6):723-734. [20]Wu B,Jiang Y,Zhu F,et al.Demethylation effects of elemene on the GSTP1 gene in HCC cell line QGY7703[J].Oncology Letters,2016,11(4):2545-2551.

相似文献/References:

[1]修朋程,李 腾,李雅林,等.泰山山慈菇对小鼠肝癌的治疗作用及相关免疫机制研究[J].医学信息,2018,31(09):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
　XIU Peng-cheng,LI Teng,LI Ya-lin,et al.Study on the Therapeutic Effect and Mechanism of Taishan Mountain Mushroom on Liver Cancer in Mice[J].Medical Information,2018,31(24):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
[2]崔康健,杜成友.肝动脉化疗栓塞联合射频消融治疗肝癌的研究进展[J].医学信息,2018,31(09):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
　CUI Kang-jian,DU Cheng-you.Research Progress of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for Liver Cancer[J].Medical Information,2018,31(24):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
[3]李在明,魏正强.外泌体在结直肠癌中的研究进展[J].医学信息,2019,32(03):42.[doi:10.3969/j.issn.1006-1959.2019.03.014]
　LI Zai-ming,WEI Zheng-qiang.Research Progress of Exosomes in Colorectal Cancer[J].Medical Information,2019,32(24):42.[doi:10.3969/j.issn.1006-1959.2019.03.014]
[4]田 明,常伟平.UbcH10在肝癌中的表达及其与预后的关系[J].医学信息,2019,32(12):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
　IAN Ming,CHANG Wei-ping.Expression of UbcH10 in Hepatocellular Carcinoma and Its Relationship with Prognosis[J].Medical Information,2019,32(24):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
[5]许 吉.基于知识图谱和专利地图的我国抗肝癌药物研发态势研究[J].医学信息,2018,31(21):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
　XU Ji.Research and Development Situation of Anti-liver Cancer Drugs in China Based on Knowledge Map and Patent Map[J].Medical Information,2018,31(24):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
[6]兰福全,李秀云,卢 斌.四种肿瘤标志物对肝癌诊断的临床意义[J].医学信息,2018,31(21):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
　LAN Fu-quan,LI Xiu-yun,LU Bin.The Clinical Significance of Four Tumor Markers in the Diagnosis of Liver Cancer[J].Medical Information,2018,31(24):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
[7]李 闯,叶劲松,刘 昕,等.ZBP-89与缺氧信号因子HIF-1α在肝癌细胞中的 相关性研究[J].医学信息,2019,32(15):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
　LI Chuang,YE Jin-song,LIU Xin,et al.Correlation between ZBP-89 and Hypoxia Signaling Factor HIF-1α in Hepatoma Cells[J].Medical Information,2019,32(24):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
[8]赵瑶瑶,高 川,胡佳杰.循环miRNA监测肝细癌的研究[J].医学信息,2019,32(08):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
　ZHAO Yao-yao,GAO Chuan,HU Jia-jie.Research on the Study of Circulating miRNA for Monitoring Hepatocellular Carcinoma[J].Medical Information,2019,32(24):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
[9]孙 逊.性化护理对肝癌患者CT引导下射频消融术后 负性情绪及生活质量的影响[J].医学信息,2019,32(17):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
　SUN Xun.Effect of Humanized Nursing on Negative Emotion and Quality of Life after CT-guided Radiofrequency Ablation in Patients with Liver Cancer[J].Medical Information,2019,32(24):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
[10]徐 蓓,魏霞丽,常艳琴.肝癌患者术后自我饮食管理体验的质性研究[J].医学信息,2019,32(20):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
　XU Bei,WEI Xia-li,CHANG Yan-qin.Qualitative Study of Postoperative Self-Catering Management Experience in Patients with Liver Cancer[J].Medical Information,2019,32(24):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
[11]刘瀚予,贾莉莉,喻文立,等.外泌体在肝癌中的作用机制研究进展[J].医学信息,2020,33(08):26.[doi:10.3969/j.issn.1006-1959.2020.08.010]
　LIU Han-yu,JIA Li-li,YU Wen-li,et al.The Mechanism of Exosomes in Liver Cancer[J].Medical Information,2020,33(24):26.[doi:10.3969/j.issn.1006-1959.2020.08.010]

更新日期/Last Update: 1900-01-01